2014-10-29T07:16:57-05:00 2013-12-31 521853933 RIBIS JONES & MARESCA PA 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2013-01-01 522320756 ACCELERATE BRAIN CANCER CURE INC ACCE 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 MAX WALLACE PRESIDENT AND CEO 2024193140 2014-10-14 1 DAVID JONES P01361002 4108840220 2013 2015-11-30 17:44:51Z MAX WALLACE 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 3489192 0 X WWW.ABC2.ORG X 2001 DC ACCELERATE BRAIN CANCER CURE HAS A SINGLE FOCUS-TO HASTEN THE DISCOVERY OF A CURE FOR BRAIN CANCER. 9 9 6 0 0 0 1874906 2931111 0 0 208 -10590 22134 0 1897248 2920521 889386 75000 0 0 638846 821382 0 0 573969 561278 488748 2089510 1385130 -192262 1535391 2048399 3643045 668269 727524 1380130 2915521 THE PRIMARY OBJECTIVE OF ACCELERATE BRAIN CANCER CURE, INC. IS TO ACCELERATE PROGRESS IN WHAT HAS BEEN AN UNDERSERVED FIELD OF RESEARCH; THE ORGANIZATION AIMS TO RAISE AWARENESS ABOUT BRAIN CANCER AND HELP MOBILIZE CRITICAL SCIENTIFIC RESEARCH THROUGH RESEARCH GRANTS. 0 0 522744 75000 ACCELERATE BRAIN CANCER CURE, INC. (ABC2) BELIEVES A FOCUSED AND AGGRESSIVE ENTREPRENEURIAL MODEL WILL INCREASE THE NUMBER OF THERAPIES DISCOVERED AND ENABLE THOSE THERAPIES TO BE AVAILABLE TO DOCTORS AND PATIENTS MORE QUICKLY. ABC2 PROVIDES RESEARCHERS WITH THE PIVOTAL SUPPORT THEY NEED TO MAKE CRITICAL BREAKTHROUGHS. IT FUNDS TRANSLATIONAL RESEARCH AIMED AT FINDING THE FASTEST POSSIBLE ROUTE TO A CURE. ABC2 SUPPORTS A RANGE OF MEDICAL RESEARCH ORGANIZATIONS. 522744 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 1 6 1 0 0 0 0 0 0 0 0 0 0 X 9 9 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA X THE ORGANIZATION 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 STACEY CASE CO-FOUNDER 1.00 X 0 0 0 STEPHEN CASE CHAIRMAN & CO-FOUNDER 1.00 X 0 0 0 NANCY PFUND MEMBER 1.00 X 0 0 0 DAVID COLE MEMBER 1.00 X 0 0 0 JEAN CASE CO-FOUNDER 1.00 X 0 0 0 DOUG HOLLADAY MEMBER 1.00 X 0 0 0 LARRY PROBST MEMBER 1.00 X 0 0 0 JONATHAN WEINBERG MEMBER 1.00 X 0 0 0 GARY WIMMER MEMBER 1.00 X 0 0 0 MAX WALLACE CHIEF EXECUTIVE OFFICER 40.00 X 251451 0 11691 DAVID SANDAK VP, SECRETARY/TREASURER 40.00 X 136520 0 19975 387971 0 31666 2 0 1 0 0 1152318 1778793 2931111 215 215 320911 331716 -10805 -10805 -10805 236955 1152318 236955 0 2920521 0 0 -10590 X 75000 75000 387971 69823 103895 214253 338451 60910 90635 186906 5775 991 1604 3180 44164 9272 9185 25707 45021 6823 10595 27603 2462 2462 43800 43800 142971 81144 3154 58673 22302 4600 2506 15196 17847 169 9855 7823 8735 3375 3672 1688 43234 31632 264 11338 157347 157347 2449 2449 15896 13097 2799 LICENSE AND REGISTRATIO 19122 1332 17790 MEALS AND ENTERTAINMENT 12583 8561 210 3812 1385130 522744 288417 573969 1940463 2749964 76567 883304 23848 4740 24341 20508 6282 3833 1239 1204 2048399 3643045 57260 74949 610622 610622 41665 387 288 668269 727524 X 1303563 2007863 76567 907658 1380130 2915521 2048399 3643045 1535391 0 X X 0 1 X 1 0 X 1403218 2220324 2057633 1874906 3168066 10724147 1403218 2220324 2057633 1874906 3168066 10724147 1298861 9425286 3621 750 693 208 215 5487 22134 22134 10751768 2602 0.87660 0.92280 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 24341 20508 3833 3833 DUE TO AFFILIATES 288 288 X 3236720 79244 236955 316199 2920521 0 2920521 1701329 79244 236955 316199 1385130 0 1385130 PART X, LINE 2: ABC2 RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BEING SUSTAINED. ABC2 DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE ANY UNCERTAIN TAX POSITIONS. THERE WERE NO TAX LIABILITIES RECORDED FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012. ABC2'S INCOME TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE FOR A PERIOD OF THREE YEARS FROM THE DATE THEY WERE FILED, EXCEPT UNDER CERTAIN CIRCUMSTANCES. ABC2'S FORM 990 TAX RETURNS FOR THE YEARS 2010 THROUGH 2012 ARE OPEN FOR A TAX EXAMINATION BY THE INTERNAL REVENUE SERVICE, ALTHOUGH NO REQUEST HAS BEEN MADE AS OF THE DATE OF THESE FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES 236,955. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES 236,955. RACE FOR HOPE FUNDRAISING EVENT-DC 1060960 945231 115729 115729 CITY SPECIFIC WALKS 328313 207087 121226 121226 1389273 1152318 236955 236955 236955 0 1 PRANA THERAPEUTICS INC 2210 NW 28 STREET GAINEAVILLE FL 32605 461568544 75000 THE DEVELOPMENT OF CANCEMA, A THERAPEUTIC PROTOCOL THAT INVOLVES THE DELIVERY OF A COMBINATION OF SEVERAL MOLECULAR THERAPEUTICS WHICH ARE ABLE TO TARGET MULTIPLE PATHWAYS KNOWN TO CONTRIBUTE TO GLIOBASTOMA [GB] PROLIFERATION AND THE DEVELOPMENT OF ACQUIRED RESISTANCE. 1 PART I, LINE 2: ABC2 CLOSELY MONITORS THE PROGRESS OF THE RESEARCHERS IT FUNDS THROUGH ITS GRANT PROGRAM. THE ORGANIZATION REQUIRES SCIENTIFIC PROGRESS REPORTS AND COMPLETE FINANCIAL ACCOUNTING OF EXPENDITURES BEFORE RELEASING ADDITIONAL FUNDS AS WELL AS FINAL GRANT REPORTS INCLUDING FINANCIAL REPORTS. IN ADDITION, ABC2 HOLDS AN ANNUAL SCIENTIFIC MEETING AT WHICH TIME CERTAIN GRANTEES PRESENT THEIR PROGRESS. X X X 0 0 0 0 0 0 0 0 0 MAX WALLACE CHIEF EXECUTIVE OFFICER 251451 0 0 0 0 0 0 0 11691 0 263142 0 0 0 DAVID SANDAK VP, SECRETARY/TREASURER 136520 0 0 0 0 0 2750 0 17225 0 156495 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 STEPHEN CASE, CHAIRMAN & BOARD MEMBER AND JEAN CASE, BOARD MEMBER ARE CO-FOUNDERS AND SPOUSES. STACEY CASE, BOARD MEMBER AND CO-FOUNDER, IS THE SISTER-IN-LAW OF STEPHEN CASE. THESE BOARD MEMBERS ALSO HAVE BUSINESS RELATIONSHIPS. FORM 990, PART VI, SECTION B, LINE 11 MAX WALLACE, THE CHIEF EXECUTIVE OFFICER OF ACCELERATE BRAIN CANCER CURE, INC. REVIEWS AND SIGNS THE 990. THE 990 IS ALSO REVIEWED BY THE FINANCE COMMITTEE BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS REVIEWS THE CONFLICT OF INTEREST POLICY AT ITS ANNUAL BOARD MEETING. INDEPENDENCE IS ALSO CONFIRMED PRIOR TO THE AWARDING OF ANY EXPENDITURE RESPONSIBILITY GRANT. FORM 990, PART VI, SECTION B, LINE 15A THE CHIEF EXECUTIVE OFFICER JOINED THE ORGANIZATION IN 2008. AS PART OF THE EXECUTIVE SEARCH PROCESS AN INDEPENDENT SEARCH FIRM PERFORMED AN INDUSTRY COMPENSATION ANALYSIS. THE LAST COMPENSATION REVIEW TOOK PLACE ON MARCH 6, 2012, AND UTILIZED AN INDEPENDENT COMPENSATION CONSULTANT, COPIES OF SIMILAR SIZE ORGANIZATIONS' FORMS 990 AND A COMPENSATION STUDY. THE ORGANIZATION HAD NO KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANICAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING & PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 81,144. MANAGEMENT AND GENERAL EXPENSES 3,154. FUNDRAISING EXPENSES 58,673. TOTAL EXPENSES 142,971. FORM 990, PART XII, LINE 2 C: THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.